A comparison of Guduchyadi Anjana and Olopatadine eye drops in the treatment of Allergic eye infection

A standard controlled clinical study of Guduchyadi Anjana and Olopatadine(0.2%)eye drops in the management of simple allergic conjunctivitis.

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/04/018830

Enrollment

Registered

2019-04-29

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H108- Other conjunctivitis

Interventions

Intervention1: Guduchyadi Anjana: Guduchyadi anjana will be prepared by Vati kalpana mentioned in sharangdhar samhita(uttarkhand 13/98-99) and vati will be applied to the patient by rolling two times

Eligibility

Inclusion criteria

Inclusion criteria: known case of simple allergic conjunctivitis

Exclusion criteria

Exclusion criteria: 1.known case of congenital anomalies of eye 2.known case of any other known occular pathology,conjunctivitis with corneal involvement 3.known case of bacterial conjunctivitis,viral conjunctivitis and any other occular infections 4.one eye patient

Design outcomes

Primary

Measure	Time frame
To study the efficacy of Guduchyadi anjana and olopatadine0.2% eye drops in simple allergic conjunctivitisTimepoint: 7 days with follow up on 7th,147th,21st and 28th day	—

Secondary

Measure	Time frame
To observe the adverse effects if anyTimepoint: 28 days	—

Countries

India

Contacts

Public ContactDr Rujuta Prakash Chandanshive

PDEAs college of ayurveda and research centre

virkar.chandana@gmail.com9822199107

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026